» Articles » PMID: 39340042

Advancing Human Vaccine Development Using Humanized Mouse Models

Overview
Date 2024 Sep 28
PMID 39340042
Authors
Affiliations
Soon will be listed here.
Abstract

The development of effective vaccines against infectious diseases remains a critical challenge in global health. Animal models play a crucial role in vaccine development by providing valuable insights into the efficacy, safety, and mechanisms of immune response induction, which guide the design and formulation of vaccines. However, traditional animal models often inadequately recapitulate human immune responses. Humanized mice (hu-mice) models with a functional human immune system have emerged as invaluable tools in bridging the translational gap between preclinical research and clinical trials for human vaccine development. This review summarizes commonly used hu-mice models and advances in optimizing them to improve human immune responses. We review the application of humanized mice for human vaccine development with a focus on HIV-1 vaccines. We also discuss the remaining challenges and improvements needed for the currently available hu-mice models to better facilitate the development and testing of human vaccines for infectious diseases.

References
1.
Ren D, Liu W, Ding S, Li Y . Protocol for generating human immune system mice and hydrodynamic injection to analyze human hematopoiesis . STAR Protoc. 2022; 3(1):101217. PMC: 8899045. DOI: 10.1016/j.xpro.2022.101217. View

2.
Legrand N, Ploss A, Balling R, Becker P, Borsotti C, Brezillon N . Humanized mice for modeling human infectious disease: challenges, progress, and outlook. Cell Host Microbe. 2009; 6(1):5-9. PMC: 7038630. DOI: 10.1016/j.chom.2009.06.006. View

3.
Morrissey M, Kern N, Vale R . CD47 Ligation Repositions the Inhibitory Receptor SIRPA to Suppress Integrin Activation and Phagocytosis. Immunity. 2020; 53(2):290-302.e6. PMC: 7453839. DOI: 10.1016/j.immuni.2020.07.008. View

4.
Cheng L, Zhang Z, Li G, Li F, Wang L, Zhang L . Human innate responses and adjuvant activity of TLR ligands in vivo in mice reconstituted with a human immune system. Vaccine. 2017; 35(45):6143-6153. PMC: 5641266. DOI: 10.1016/j.vaccine.2017.09.052. View

5.
Shultz L, Brehm M, Garcia-Martinez J, Greiner D . Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol. 2012; 12(11):786-98. PMC: 3749872. DOI: 10.1038/nri3311. View